Contribute Try STAT+ Today

SILVER SPRING, Md. — Government advisers dealt a blow Thursday to Philip Morris International’s hopes to sell its heat-not-burn device in the United States as a less-harmful alternative to cigarettes.

The pen-like device heats Marlboro-branded sticks of tobacco but stops short of burning them. It is already sold in more than 30 countries, and Philip Morris aims to make it the first “reduced risk” tobacco product ever sanctioned by the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • When you’re addicted to cigarettes, you’re not only addicted to nicotine. You’re also addicted to the act of smoking. That’s why transdermal nicotine patches and vaping don’t work for everyone. This product comes closer to the smoking experience without using combustion, thus avoiding the witches brew of chemicals generated by burning. If it allows some people to move off of traditional cigarettes, that’s a good thing, and FDA should cut Philip Morris a break. We need more alternatives.

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy